$NVCR NovoCure Ltd Insider Trading Week 45/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovoCure Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NovoCure Ltd in week 45/2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 7.03 | 2,407 | 16,921 | 33,979 | |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 20,000 | 68,800 | 25,832 | |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 5,169 | 17,781 | 0 | |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 7.03 | 10,000 | 70,300 | 36,386 | |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 20,000 | 68,800 | 45,832 | |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 10,000 | 34,400 | 5,169 | |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 82.62 | 504 | 41,642 | 87,179 | 87.7 K to 87.2 K (-0.57 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 81.80 | 1,403 | 114,771 | 87,683 | 89.1 K to 87.7 K (-1.57 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.96 | 500 | 40,478 | 89,086 | 89.6 K to 89.1 K (-0.56 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 7.03 | 2,407 | 16,921 | 89,586 | 87.2 K to 89.6 K (+2.76 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 82.54 | 7,200 | 594,252 | 87,179 | 94.4 K to 87.2 K (-7.63 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 81.67 | 10,800 | 881,993 | 94,379 | 105.2 K to 94.4 K (-10.27 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.78 | 2,000 | 161,556 | 105,179 | 107.2 K to 105.2 K (-1.87 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 20,000 | 68,800 | 107,179 | 87.2 K to 107.2 K (+22.94 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 82.50 | 1,764 | 145,526 | 87,179 | 88.9 K to 87.2 K (-1.98 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 81.66 | 2,805 | 229,062 | 88,943 | 91.7 K to 88.9 K (-3.06 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.68 | 600 | 48,409 | 91,748 | 92.3 K to 91.7 K (-0.65 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 5,169 | 17,781 | 92,348 | 87.2 K to 92.3 K (+5.93 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 81.16 | 2,542 | 206,304 | 87,179 | 89.7 K to 87.2 K (-2.83 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.79 | 7,458 | 602,495 | 89,721 | 97.2 K to 89.7 K (-7.67 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 7.03 | 10,000 | 70,300 | 97,179 | 87.2 K to 97.2 K (+11.47 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 81.13 | 6,332 | 513,684 | 87,179 | 93.5 K to 87.2 K (-6.77 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.72 | 13,668 | 1,103,240 | 93,511 | 107.2 K to 93.5 K (-12.75 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 20,000 | 68,800 | 107,179 | 87.2 K to 107.2 K (+22.94 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 81.16 | 2,458 | 199,486 | 87,179 | 89.6 K to 87.2 K (-2.74 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.80 | 7,542 | 609,409 | 89,637 | 97.2 K to 89.6 K (-7.76 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 10,000 | 34,400 | 97,179 | 87.2 K to 97.2 K (+11.47 %) |
| Nov 13 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 5,000 | 17,200 | 4,743 | |
| Nov 13 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 79.57 | 5,000 | 397,850 | 69,504 | 74.5 K to 69.5 K (-6.71 %) |
| Nov 13 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 5,000 | 17,200 | 74,504 | 69.5 K to 74.5 K (+7.19 %) |
| Nov 13 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 82.14 | 2,100 | 172,498 | 809,465 | 811.6 K to 809.5 K (-0.26 %) |
| Nov 13 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 81.59 | 11,118 | 907,118 | 811,565 | 822.7 K to 811.6 K (-1.35 %) |
| Nov 13 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 80.11 | 29,782 | 2,385,776 | 822,683 | 852.5 K to 822.7 K (-3.49 %) |